Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-13
2008-05-06
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S429000, C514S617000, C546S195000, C548S567000, C564S337000
Reexamination Certificate
active
07368462
ABSTRACT:
The present invention relates to compounds capable of serving as moderators of human and mammalian appetite and as such provide a means for reducing body mass and controlling obesity.
REFERENCES:
CAPLUS listing AN:2003:319711, “Preparation of 2′-methyl-5′-(1,3,4-oxadiazol-2-yl)-1, 1′-biphenyl-4-carboxamides as p38 kinase inhibitors,” Angell et al. (2003).
Clay Cynthia L.
Coppins Janet L.
McDow Kelly L.
Saeed Kamal A.
The Procter & Gamble & Company
LandOfFree
Melanin concentrating hormone antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanin concentrating hormone antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanin concentrating hormone antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3985725